FDA Approves

FDA Approves Thermo Fisher’s Oncomine Dx Target Test as Companion Diagnostic for Bayer’s New HER2-Directed Therapy HYRNUO™

Precision Medicine

FDA Approves Thermo Fisher’s Oncomine Dx Target Test as Companion Diagnostic for Bayer’s New HER2-Directed Therapy HYRNUO™

21 Nov 2025

2 min read

FDA Approves GSK’s Blenrep Combination Therapy for Relapsed or Refractory Multiple Myeloma

FDA Approves GSK’s Blenrep Combination Therapy for Relapsed or Refractory Multiple Myeloma

24 Oct 2025

3 min read

FDA Approves Boehringer Ingelheim’s Jascayd (nerandomilast) as First New Therapy in Over a Decade for IPF

FDA Approves Boehringer Ingelheim’s Jascayd (nerandomilast) as First New Therapy in Over a Decade for IPF

09 Oct 2025

1 min read

Read More

Voice Of HealthCare

vohnetwork.com